From HRSA Maternal & Child Health
"HRSA is considering recommending the Secretary of Health and Human Services add Metachromatic Leukodystrophy (MLD) and Duchenne Muscular Dystrophy (DMD) to the Recommended Uniform Screening Panel (RUSP). HRSA is providing notice and requesting comments from the public on these potential recommendations. The notices can be found here: MLD Federal Register Notice and DMD Federal Register Notice.
We are particularly interested in comments that address the potential benefit of early screening for these conditions within the newborn period, the ability of state newborn screening programs to screen for them, and the availability of effective treatments. See the evidences reviews for MLD and DMD for additional information.
Submit comments by September 15, 2025."
Comments